Trials / Conditions / Adenocarcinoma of the Bladder
Adenocarcinoma of the Bladder
4 registered clinical trials studyying Adenocarcinoma of the Bladder — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE) NCT06041503 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carci NCT03430895 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium NCT00407485 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium NCT00112905 | National Cancer Institute (NCI) | Phase 2 |